WallStreetZenWallStreetZen

NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rocket Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martin WilsonGeneral Counsel2026-02-181,376$3.34
$4.59kSell
Gaurav ShahCEO2026-02-185,990$3.34
$19.99kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2026-02-181,157$3.34
$3.86kSell
Martin WilsonGeneral Counsel2026-02-1312,253$3.31
$40.58kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2026-02-133,726$3.31
$12.34kSell
Gaurav ShahCEO2026-02-1312,279$3.31
$40.67kSell
Elisabeth BjorkDirector2026-01-0210,000$3.44
$34.40kBuy
Gaurav ShahCEO2025-11-186,276$2.98
$18.72kSell
Martin WilsonGeneral Counsel2025-11-181,646$2.98
$4.91kSell
Jonathan David SchwartzChief Science Gene Therapy Officer2025-11-182,545$2.98
$7.59kSell

1 of 5

RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCKT insiders and whales buy or sell their stock.

RCKT Shareholders

What type of owners hold Rocket Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roderick Wong31.89%34,508,759$149.42MInsider
Rtw Investments LP31.14%33,696,243$145.90MInsider
Rtw Investments LP16.34%17,687,772$76.59MInstitution
Vanguard Group Inc7.90%8,544,423$37.00MInstitution
Blackrock Inc7.31%7,906,071$34.23MInstitution
Citigroup Inc4.85%5,246,349$22.72MInstitution
Morgan Stanley3.64%3,941,377$17.07MInstitution
Devon Park Associates LP3.01%3,253,566$14.09MInsider
Devang Kantesaria3.00%3,243,709$14.05MInsider
Devon Park Bioventures LP3.00%3,243,709$14.05MInsider

1 of 3

RCKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCKT48.96%51.04%Net SellingNet Selling
SLDB55.23%44.77%Net SellingNet Selling
TRDA41.71%58.29%Net Selling
LYEL0.49%99.51%Net BuyingNet Selling
CLYM45.65%9.29%Net BuyingNet Buying
View Top Biotech Stocks

Rocket Pharmaceuticals Stock Ownership FAQ

Who owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals (NASDAQ: RCKT) is owned by 84.04% institutional shareholders, 87.62% Rocket Pharmaceuticals insiders, and 0.00% retail investors. Roderick Wong is the largest individual Rocket Pharmaceuticals shareholder, owning 34.51M shares representing 31.79% of the company. Roderick Wong's Rocket Pharmaceuticals shares are currently valued at $156.32M.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.